Metastatic Breast Cancer
Showing 1 - 25 of >10,000
HER2-positive Breast Cancer Trial in Amsterdam (Trastuzumab deruxtecan)
Not yet recruiting
- HER2-positive Breast Cancer
- Trastuzumab deruxtecan
-
Amsterdam, NetherlandsAntoni van Leeuwenhoek
Aug 7, 2023
Discovering Factors in Metastatic Breast Cancer Patients'
Not yet recruiting
- Metastatic Breast Cancer
- (no location specified)
Feb 25, 2023
Metastatic Breast Cancer Trial in Philadelphia (Adapted Intimacy Enhancement, Intimacy Facts and Resources)
Recruiting
- Metastatic Breast Cancer
- Adapted Intimacy Enhancement
- Intimacy Facts and Resources
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Dec 5, 2022
Metastatic Breast Cancer-Specific Prognostic Tool
Recruiting
- Metastatic Breast Cancer
- Patients and Caregivers Qualitative Interview
-
Chapel Hill, North CarolinaTerri Eubanks
Oct 7, 2022
Breast Cancer, Metastatic Breast Cancer, Radiation Therapy Complication Trial in Seoul
Recruiting
- Breast Cancer
- +2 more
-
Seoul, Korea, Republic ofSamsung Medical Center
Jun 8, 2023
Using a Blood Test to Monitor Metastatic Breast Cancer Treatment
Not yet recruiting
- Metastatic Breast Cancer
-
Kingston, Ontario, Canada
- +1 more
Mar 27, 2023
Metastatic Breast Cancer, Lobular Breast Carcinoma Trial in San Francisco (Blood Specimen)
Not yet recruiting
- Metastatic Breast Cancer
- Lobular Breast Carcinoma
- Blood Specimen
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jul 19, 2023
Germline and Somatic Pathogenic Variants in de Novo Metastatic
Active, not recruiting
- Metastatic Breast Cancer
- NGS in blood and Formalin-Fixed Paraffin-Embedded (FFPE) tissue
-
Athens, GreeceEvangelia Moirogiorgou
Mar 7, 2023
Metastatic Breast Cancer Trial in Milwaukee (Lifestyle Intervention)
Recruiting
- Metastatic Breast Cancer
- Lifestyle Intervention
- Attention Control
-
Milwaukee, WisconsinMedical College of Wisconsin
Dec 16, 2022
Metastatic Breast Cancer Trial (BDC-1001, Pertuzumab)
Not yet recruiting
- Metastatic Breast Cancer
- (no location specified)
Jul 12, 2023
Breast Cancer Trial (SHR-A1811, Capecitabine/Eribulin/Gemcitabine/Paclitaxel/Nab-paclitaxel)
Not yet recruiting
- Breast Cancer
- (no location specified)
Apr 3, 2023
Breast Cancer, Lipid Cell; Tumor, Nutrition Related Cancer Trial in Roma (Lipidomic analysis for breast cancer patients)
Not yet recruiting
- Breast Cancer
- +3 more
- Lipidomic analysis for breast cancer patients
-
Roma, ItalyFondazione Policlinico Universitario A. Gemelli IRCCS
Sep 4, 2023
Triple Negative Breast Cancer, Metastatic Breast Cancer Trial (Sacituzumab govitecan)
Not yet recruiting
- Triple Negative Breast Cancer
- Metastatic Breast Cancer
- Sacituzumab govitecan
- (no location specified)
Jan 23, 2023
Metastatic Breast Cancer Trial in Taipei City, Taipei, Yuanlin (Olaparib, Chemotherapy drug)
Recruiting
- Metastatic Breast Cancer
- Olaparib
- Chemotherapy drug
-
Taipei City, Please Select, Taiwan
- +2 more
Nov 27, 2022
Breast Cancer, HER2-negative Breast Cancer, Metastatic Breast Cancer Trial in Madison (18F-DCFPyL)
Recruiting
- Breast Cancer
- +2 more
-
Madison, WisconsinUniversity of Wisconsin School of Medicine and Public Health
Oct 18, 2022
Metastatic Breast Cancer, Brain Metastases Trial in Tampa (Nivolumab, Stereotactic Radiosurgery)
Active, not recruiting
- Metastatic Breast Cancer
- Brain Metastases
- Nivolumab
- Stereotactic Radiosurgery
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Nov 17, 2022
HER2-PositiveRecurrent or Metastatic Breast Cancer Trial (SHR-A1811 Injection, SHR-A1811 Injection ; Pertuzumab Injection,
Not yet recruiting
- HER2-PositiveRecurrent or Metastatic Breast Cancer
- SHR-A1811 Injection
- +2 more
- (no location specified)
Sep 21, 2023
HER2-positive Recurrent/Metastatic Breast Cancer Trial (Inetetamab, pyrotinib, chemo)
Not yet recruiting
- HER2-positive Recurrent/Metastatic Breast Cancer
- Inetetamab, pyrotinib, chemotherapy
- (no location specified)
Nov 16, 2022
Metastatic Breast Cancer, Hyperinsulinism, Hyperglycemia Drug Induced Trial in Haifa (Pioglitazone)
Recruiting
- Metastatic Breast Cancer
- +2 more
-
Haifa, IsraelRambam Health Care Campus
Feb 22, 2023
DESTINY Breast Respond HER2-low Europe
Not yet recruiting
- Unresectable Breast Cancer
- +2 more
- Trastuzumab deruxtecan
- (no location specified)
Jul 6, 2023
Identify the Number of Eligible Patients for Immunotherapy According to the Epidemiological and Biological Profile in Tunisia
Not yet recruiting
- Identify the Number of Eligible Patients for Immunotherapy According to the Epidemiological and Biological Profile in Tunisia
- identify biomarkers
- (no location specified)
May 13, 2023
Breast Cancer Trial in Xi'an (metronomic oral vinorelbine plus anlotinib)
Recruiting
- Breast Cancer
- metronomic oral vinorelbine plus anlotinib
-
Xi'an, Shaanxi, ChinaXi'an International Medical Center Hospital
Aug 27, 2023
Metastatic Breast Cancer Trial in Charlottesville (HER2 BATs with Pembrolizumab)
Recruiting
- Metastatic Breast Cancer
- HER2 BATs with Pembrolizumab
-
Charlottesville, VirginiaAshley Donihee
Jan 18, 2023
Advanced or Metastatic Breast Cancer Trial in Paris (Milademetan, Patient Reported Outcomes (PROs) and Health-Related Quality of
Not yet recruiting
- Advanced or Metastatic Breast Cancer
- Milademetan
- Patient Reported Outcomes (PROs) and Health-Related Quality of Life (HRQOL)
-
Paris, FranceInstitut Curie
Jun 27, 2023